logo
Share SHARE
FONT-SIZE Plus   Neg

St. Jude Medical Announces CE Mark Approval Of Ellipse ICD - Quick Facts

St. Jude Medical, Inc. (STJ) announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator, or ICD. ICDs are advanced implantable cardiac devices that treat potentially lethal, abnormally fast heart rhythms that often lead to sudden cardiac death.

According to the company, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy ICD.

Dr. L.R.C. Dekker, cardiologist from the Cardiac Center of the Catharina Hospital in Eindhoven, The Netherlands, who implanted the first Ellipse ICD in Europe, said, "Its thinness, longevity and new discrimination algorithms constitute the answers to the three main concerns of patients and their doctors: decreasing the volume of the can, reducing the risk for infection during ICD replacement and minimizing inappropriate shock."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of CRH plc were gaining around 3 percent in the early morning trading in London after the building materials group reported Thursday higher profit in its first half with improved sales. The company also announced its agreement to sell Americas Distribution business to Beacon Roofing Supply, Inc. for $2.63 billion in cash or about 2.2 billion euros. Private equity firm Blackstone Group LP is exploring options for a potential initial public offering of Gates Global LLC, Reuters reported, citing people familiar with the matter. As per the report, an IPO, which could occur as soon as 2018, could value Gates at more than $7 billion. Apple Inc. is working on a self-driving shuttle service to ferry employees within its sprawling campus, the New York Times reported. The move comes after the tech giant decided to abandon the idea of building an entire self-driving car by itself.
comments powered by Disqus
Follow RTT